Skip to main content
The BMJ logoLink to The BMJ
. 1996 Mar 16;312(7032):704–705.

Effect of adding selegiline to levodopa in early, mild Parkinson's disease

A J Lees, J Head, Y Ben-Shlomo
PMCID: PMC2350554

Full text

PDF
704

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ben-Shlomo Y., Marmot M. G. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? J Neurol Neurosurg Psychiatry. 1995 Mar;58(3):293–299. doi: 10.1136/jnnp.58.3.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bennett D. A., Beckett L. A., Murray A. M., Shannon K. M., Goetz C. G., Pilgrim D. M., Evans D. A. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med. 1996 Jan 11;334(2):71–76. doi: 10.1056/NEJM199601113340202. [DOI] [PubMed] [Google Scholar]
  3. Clarke C. E. Does levodopa therapy delay death in Parkinson's disease? A review of the evidence. Mov Disord. 1995 May;10(3):250–256. doi: 10.1002/mds.870100303. [DOI] [PubMed] [Google Scholar]
  4. Hughes A. J., Daniel S. E., Kilford L., Lees A. J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181–184. doi: 10.1136/jnnp.55.3.181. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES